{"id":"W4285043434","doi":"10.1200/jco.22.00825","title":"Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital; Princess Margaret Cancer Centre; Queen's University; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Nivolumab; Medicine; Ipilimumab; Atezolizumab; Oncology; Internal medicine; Guideline; Lung cancer; Chemotherapy; Cancer; Clinical trial; Randomized controlled trial; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005126186,0.000144298,0.001004015,0.0001271987,0.000176137,0.00001456623,0.0002220899,0.0001605641,0.002389985],"category_scores_gemma":[0.0005272438,0.000107899,0.0006864687,0.0001440399,0.00009196483,0.00008762671,0.00006047665,0.0007984402,0.000001313413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003678116,"about_ca_system_score_gemma":0.003073298,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008501461,"about_ca_topic_score_gemma":0.00008537981,"domain_scores_codex":[0.9964247,0.0003567063,0.00243716,0.000207921,0.0003299827,0.0002435438],"domain_scores_gemma":[0.9958417,0.001519749,0.001777002,0.0002001394,0.0004822322,0.0001791829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05391499,0.005606599,0.2631986,0.0001356878,0.002882478,0.000255891,0.001546552,0.001155375,0.01784933,0.0000386765,0.2448883,0.4085275],"study_design_scores_gemma":[0.02186409,0.0149354,0.04044252,0.0001064516,0.0003576102,0.0001047382,0.0004691797,0.004558553,0.0002843806,0.00002575262,0.9166796,0.0001717673],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9670058,0.006690022,0.005263888,0.01527648,0.003813823,0.0009397907,0.0000349431,0.00001453695,0.0009606726],"genre_scores_gemma":[0.911392,0.01030864,0.019621,0.04241209,0.004877418,0.0001896626,0.0000149047,0.00007075587,0.01111353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6717913,"threshold_uncertainty_score":0.998522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1036405909442447,"score_gpt":0.4805426847156378,"score_spread":0.3769020937713932,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}